SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Altea Therapeutics and KAI Pharmaceuticals, Inc. Enter into a Preclinical and Clinical Development Agreement for the Transdermal Delivery of Certain Novel KAI Peptides